South America Latent TB Detection Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)

Code: TIPRE00024702 | Pages: 107 | Industry: Medical Device | Date: Sep 2021 | Type: Regional

Market Introduction

SAM region consists of Brazil and Rest of SAM. Brazil is expected to have the major market share in this region. Also, it is projected to grow with highest growth rate. Tuberculosis is an infectious disease that affects the lungs. TB elimination requires treatment of millions of persons with latent tuberculosis infection. Brazil has shown a decline in incidence and mortality rates owing to the performance of TB control programs. However, the disease burden continues to be significant, Brazil is one of the 30 high TB burden countries. As per the WHO, in 2018, around 76,000 new TB cases and 4500 TB deaths were reported in Brazil. Many organizations are involved in control programs to achieve the specific targets of the sustainable development goals (SDGs) until 2030 and World Health Organization (WHO)’s End TB Strategy to end the TB epidemic by 2035. For instance, the Unitaid-funded IMPAACT4TB project (2017-2021) has been working in 12 high-burden countries, including Brazil. In addition, government in the country is helping people suffering from TB. For instance, in November 2019, the Government of Brazil announced 70% discount on rifapentine to 30,000 people receiving treatment that year. The price reduction of latent TB treatment is a step forward in tackling the disease, and in improving the lives of people. Increasing prevalence of tuberculosis and growth of market in emerging economies are the major factor driving the growth of the SAM latent TB detection market. 

In case of COVID-19, SAM is highly affected especially Brazil followed by Argentina and Columbia. The COVID-19 pandemic has become the most significant challenge in the region. The region's situation is deteriorating as a result of economic uncertainty and ongoing conflicts. Several countries, for example, are undergoing violent conflict and are unable to implement any public health measures. However, the recent pandemic is causing havoc in the SAM region's economies. A sudden drop in domestic and external demand for goods and products, and halted production due to labor shortage, are major impacts observed in the region. Additionally, tightened financial condition is also decreasing the economic activities in the region. The COVID-19 pandemic has had enormous health, social, and economic consequences since the beginning of 2020, and it is expected to continue in 2021 and beyond. Even after some of these effects are mitigated or contained, there will be medium- and long-term consequences, including for the tuberculosis epidemic and response.  The pandemic has the potential to reverse progress toward TB targets by the end of 2019. People with tuberculosis in the region, for example, reported significant difficulties in accessing TB services during the pandemic and associated lockdowns. Difficulties in obtaining transportation to access TB care, as well as increased stigma due to the similar symptoms of both respiratory diseases, have complicated TB management.    


Get more information on this report :



Market Overview and Dynamics

The SAM latent TB detection market is expected to grow from US$ 99.15 million in 2020 to US$ 133.10 million by 2027; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027. Advancements in tuberculosis diagnosis is expected to catalyze the market growth. Fluorescent stamping, antigen detection, ELISA, modified culture methods, and antigen preparations are among the advanced procedures practiced for the diagnosis of TB across the region. Manufacturers and researchers are consistently working toward finding new and viable solutions that are based on potent technologies to accurately diagnose TB. For instance, in July 2020, Cepheid, Inc. and The Foundation for Innovative New Diagnostics (FIND) introduced a new drug-resistant tuberculosis-profiling test that provides test results in 90 min. Moreover, the accessibility of blood-based diagnostics in the form of interferon γ release assays (IGRAs) have helped clinicians deliver reliable test results for diagnosing latent TB infection with high specificity and sensitivity. Thus, the consistent advancements in TB diagnosis is likely to be a prevalent trend in the SAM market during the coming years. 

Key Market Segments

In terms of test, the tuberculin skin test (TST) segment accounted for the largest share of the SAM latent TB detection market in 2019. In terms of end user, the hospitals segment held a larger market share of the SAM latent TB detection market in 2019.   

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the SAM latent TB detection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ARKRAY, Inc.; BD; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Oxford Immunotec Ltd; QIAGEN; and Serum Institute of India Pvt. Ltd. 

Reasons to buy report

  • To understand the SAM latent TB detection market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM latent TB detection market 
  • Efficiently plan M&A and partnership deals in SAM latent TB detection market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM latent TB detection market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in SAM region.

SAM Latent TB Detection Market Segmentation

SAM Latent TB Detection Market - By Test

  • Tuberculin Skin Test (TST) 
  • Interferon Gamma Released Assay (IGRA)

SAM Latent TB Detection Market - By End User

  • Hospitals
  • Diagnostic Centers  
  • Laboratories
  • Others

SAM Latent TB Detection Market - By Country

  • Brazil
  • Argentina    
  • Rest of SAM 

SAM Latent TB Detection Market - Company Profiles

  • Abbott
  • ARKRAY, Inc.
  • BD
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Oxford Immunotec Ltd
  • QIAGEN    
  • Serum Institute of India Pvt. Ltd.

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Latent TB Detection Market – By Test

1.3.2        SAM Latent TB Detection Market – By End User

1.3.3        SAM Latent TB Detection Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Latent TB Detection Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

5.           SAM Latent TB Detection Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Tuberculosis

5.1.2        Government Initiatives to Promote Tuberculosis Detection

5.2         Market Restraints

5.2.1        Presence of Multidrug Resistant Tuberculosis (MDR-TB)

5.3         Market Opportunities

5.3.1        Growth of Market in Emerging Economies

5.4         Future Trends

5.4.1        Advancements in Tuberculosis Diagnosis

5.5         Impact Analysis

6.           Latent TB Detection Market – SAM Analysis

6.1         SAM Latent TB Detection Market Revenue Forecast and Analysis

7.           SAM Latent TB Detection Market Analysis – By Test

7.1         Overview

7.2         SAM Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

7.3         Tuberculin Skin Test (TST)

7.3.1        Overview

7.3.2        Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

7.4         Interferon Gamma Released Assay (IGRA)

7.4.1        Overview

7.4.2        Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.           SAM Latent TB Detection Market Analysis – By End User

8.1         Overview

8.2         SAM Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.5         Laboratories

8.5.1        Overview

8.5.2        Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

9.           SAM Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis

9.1         SAM: Latent TB Detection Market

9.1.1        Overview

9.1.2        SAM: Latent TB Detection Market, by Country, 2019 & 2027 (%)

9.1.3        Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          Brazil Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.3.3          Brazil Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.4        Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Argentina Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Argentina Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on SAM Latent TB Detection Market

10.1      SAM: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      QIAGEN

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      bioMerieux SA

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      F. HOFFMANN-LA ROCHE LTD.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Abbott

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Oxford Immunotec Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      ARKRAY, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Serum Institute of India Pvt. Ltd.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             SAM Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)

Table 2.             Brazil Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 4.             Argentina Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 5.             Argentina Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 6.             Organic Developments Done By Companies

Table 7.             Inorganic Developments Done By Companies

Table 8.             Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Latent TB Detection Market Segmentation

Figure 2.           SAM Latent TB Detection Market – By Country

Figure 3.           SAM Latent TB Detection Market Overview

Figure 4.           Tuberculin Skin Test (TST) Segment Held Largest Share of SAM Latent TB Detection Market

Figure 5.           Brazil to Show Remarkable Growth During Forecast Period

Figure 6.           SAM PEST Analysis

Figure 7.           SAM Latent TB Detection Market Impact Analysis of Drivers and Restraint

Figure 8.           SAM Latent TB Detection Market – Revenue Forecast and Analysis

Figure 9.           SAM Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

Figure 10.        SAM Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 11.        SAM Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        SAM Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

Figure 13.        SAM Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        SAM Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        SAM Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        SAM Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        SAM: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        SAM: Latent TB Detection Market, by Country, 2019 & 2027 (%)

Figure 19.        Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        Impact Of COVID-19 Pandemic in SAM Market

  1. Abbott
  2. ARKRAY, Inc.
  3. BD
  4. bioMerieux SA
  5. F. HOFFMANN-LA ROCHE LTD.
  6. Oxford Immunotec Ltd
  7. QIAGEN    
  8. Serum Institute of India Pvt. Ltd.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000